Name | Dithranol |
Synonyms | Lasan Psorin derobin Micanol Psorider cygnolin cignolin dermaline DITHRANOL 9-anthrol batridrol DithraSal Dithranol anthralin psoriacide Dithrocream Anthraforte anthra-derm chrysodermol psoriacid-stift anthracene-1,8,9-triol 1,8-dihydroxy-anthrone 1,8-dihydroxy-9-anthrone 1,8-dihydroxyanthracen-9(10H)-one 1,8-dihydroxy-9(10H)-anthracenone 1,8,9-ANTHRACENETRIOL, PGE. WITH 10 X 10 MG |
CAS | 1143-38-0 |
EINECS | 214-538-0 |
InChI | InChI=1/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-7,15-17H |
InChIKey | NUZWLKWWNNJHPT-UHFFFAOYSA-N |
Molecular Formula | C14H10O3 |
Molar Mass | 226.23 |
Density | 1.419±0.06 g/cm3(Predicted) |
Melting Point | 178-181 °C (lit.) |
Boling Point | 464.1±45.0 °C(Predicted) |
Flash Point | 229.7°C |
Water Solubility | Insoluble in water. Soluble in acetic acid, chloroform (20 mg/mL), acetone, benzene, solutions of alkali hydroxides, fixed oil. Slightly soluble in 95% ethanol, alcohol, ether, and glacial acetic acid |
Solubility | Practically insoluble in water, soluble in methylene chloride, sparingly soluble in acetone, slightly soluble in ethanol (96 per cent). It dissolves in dilute solutions of alkali hydroxides. |
Vapor Presure | 5.23E-09mmHg at 25°C |
Appearance | Yellow to orange powder |
Color | Yellow to Orange to Dark Yellow |
Merck | 14,684 |
BRN | 2054360 |
pKa | 7.16±0.20(Predicted) |
Storage Condition | 2-8°C |
Stability | Stable. Combustible. Incompatible with strong oxidizing agents. |
Refractive Index | 1.837 |
MDL | MFCD00053409 |
Use | Dermatologic agents, for the treatment of psoriasis |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R45 - May cause cancer |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S53 - Avoid exposure - obtain special instructions before use. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
WGK Germany | 3 |
RTECS | CB8927000 |
HS Code | 29144000 |
Reference Show more | 1. [IF=5.115] Lingyun Wu et al."Cyclodextrin-Modified CeO2 Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis."Int J Nanomed. 2020; 15: 2515–2527 |
This product is 1, 8-dihydroxy-9-anthrone. Calculated as dried product, containing no less than 95.0% of C14H1003.
The melting point of this product (General 0612) is 176~181°C.
take l.Og of this product, add 25ml of water, shake well, filter; Take 10ml of continued filtrate, add 2 drops of Methyl red indicator, and do not appear red.
take this product and add three kinds of methane to make about 0.10 mg of the solution, according to UV-visible spectrophotometry (General 0401), at the wavelength of 0.12 nm absorbance measurement, not more.
take this product, dry to constant weight at 105°C, weight loss shall not exceed 0.5% (General rule 0831).
take l.Og of this product and check it according to law (General rule 0841). The residue left shall not exceed 0.1%.
The residue left under the item of burning residues shall not contain more than 20 parts per million of heavy metals after examination by law (General rule 0821, Law II).
take this product, precision weighing, and chloroform dissolved and quantitatively diluted to make a solution containing about lOug per lml. The absorbance was measured at a wavelength of 0401 NM according to ultraviolet-visible spectrophotometry (General rule 463), and the absorption coefficient of C14H10O3 was calculated.
psoriasis medication.
light shielding, sealed storage.
This product contains dianthrol (C14H1003) should be the label amount of 85.0% ~ 110.0%.
This product is yellow ointment.
should comply with the relevant requirements under soft AIDS (General rule 0109).
take an appropriate amount of this product (about 2mg equivalent to dianthrol), precisely weigh it, put it in a 50ml beaker, add 10ml of glacial acetic acid, put it on a water bath and heat it to melt the matrix, stir and extract it for 3 minutes, cool in a cold water bath to solidify the matrix, filter the extract solution, place the filtrate in a 50ml measuring flask, extract the Matrix 3 times with the same method, and use 10ml of glacial acetic acid each time, add glacial acetic acid to dilute to the scale, shake well, as a test solution; Take the right amount of the reference substance of dianthrol, precisely weigh, dissolve and quantitatively dilute with glacial acetic acid to make a solution containing about 40ug of dianthrol per 1 ml, as a control solution. Take 5ml of the test solution and 5ml of the reference solution respectively, put them in 25ml measuring flasks respectively, and add 1 ml of 5% sodium nitrite solution (freshly prepared) respectively, and shake them well, it was heated in a boiling water bath for 3 minutes, removed, immediately allowed to cool, diluted to the scale with glacial acetic acid, and shaken (filtered if necessary). According to ultraviolet-visible spectrophotometry (General rule 0401), the absorbance was measured at a wavelength of NM and calculated.
The same as dianthrol.
(1 ) 0.1% (2)0.5% ( 3) 1%
light shielding, sealed storage.
(IARC) carcinogen classification | 3 (Vol. 13; Sup 7) 1987 |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
biological activity | Dithranol (Anthralin) is an anthraquinone derivative with strong anti-psoriasis effect. Dithranol can inhibit DNA replication and repair. |
Cell Line: | HaCaT cells |
Concentration: | 0.1 μg/mL, 0.25 μg/mL, 0.5 μg/mL |
Incubation Time: | 2 hours, 4 hours |
Result: | Increased the mRNA production of interleukin-10 receptors in HaCaT cells. |
uses | dermatological drugs to treat psoriasis. Dermatology, used to treat psoriasis |